How Can We Improve Antimicrobial Stewardship in Solid Organ Transplant Patients?
AUG 18, 2016 | CONTAGION EDITORIAL STAFF
Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, discusses how collaboration with transplant counterparts is needed to provide optimal treatment.
Interview Transcript (slightly modified for readability)
“Increased collaboration with our transplant counterparts, [is needed] so that we [as infectious disease pharmacists] can gather more data and have more information on the optimal treatment of these patients, be it duration of therapy, what we should be using for impaired therapy, combination therapy, and how these therapies impact the immunosuppression of the patients in terms of drug [to] drug interactions.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512